These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29654295)

  • 21. Cardiovascular safety pharmacology profile of etamicastat, a novel peripheral selective dopamine-β-hydroxylase inhibitor.
    Pires NM; Loureiro AI; Igreja B; Lacroix P; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 750():98-107. PubMed ID: 25641747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.
    Lu Q; Yang Y; Villar VA; Asico L; Jones JE; Yu P; Li H; Weinman EJ; Eisner GM; Jose PA
    Hypertens Res; 2013 Aug; 36(8):684-90. PubMed ID: 23425954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor.
    Loureiro AI; Rocha JF; Fernandes-Lopes C; Nunes T; Wright LC; Almeida L; Soares-da-Silva P
    Br J Clin Pharmacol; 2014 Jun; 77(6):1017-26. PubMed ID: 24168152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Utero Exposure to Fine Particulate Matter Causes Hypertension Due to Impaired Renal Dopamine D1 Receptor in Offspring.
    Ye Z; Lu X; Deng Y; Wang X; Zheng S; Ren H; Zhang M; Chen T; Jose PA; Yang J; Zeng C
    Cell Physiol Biochem; 2018; 46(1):148-159. PubMed ID: 29614490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetylation of etamicastat, a reversible dopamine-β-hydroxylase inhibitor.
    Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
    Drug Metab Dispos; 2013 Dec; 41(12):2081-6. PubMed ID: 24013186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1.
    Cuevas S; Yang Y; Konkalmatt P; Asico LD; Feranil J; Jones J; Villar VA; Armando I; Jose PA
    Hypertension; 2015 Jun; 65(6):1251-7. PubMed ID: 25895590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.
    Yang J; Villar VAM; Jose PA; Zeng C
    Antioxid Redox Signal; 2021 Mar; 34(9):716-735. PubMed ID: 32349533
    [No Abstract]   [Full Text] [Related]  

  • 28. Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells.
    Jiang X; Konkalmatt P; Yang Y; Gildea J; Jones JE; Cuevas S; Felder RA; Jose PA; Armando I
    Hypertension; 2014 Mar; 63(3):e74-80. PubMed ID: 24379187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the dopamine D2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
    Szabo B; Crass D; Starke K
    J Pharmacol Exp Ther; 1992 Nov; 263(2):806-15. PubMed ID: 1359118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D2 receptor modulates sodium handling via local production of dopamine in the kidney.
    Ozono R; Ueda A; Oishi Y; Yano A; Kambe M; Katsuki M; Oshima T
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S75-9. PubMed ID: 14871034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells.
    Yang S; Yang Y; Yu P; Yang J; Jiang X; Villar VA; Sibley DR; Jose PA; Zeng C
    Free Radic Res; 2015 Apr; 49(4):397-410. PubMed ID: 25740199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells.
    Han F; Konkalmatt P; Chen J; Gildea J; Felder RA; Jose PA; Armando I
    Hypertension; 2015 May; 65(5):1118-25. PubMed ID: 25801876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine and renal function and blood pressure regulation.
    Armando I; Villar VA; Jose PA
    Compr Physiol; 2011 Jul; 1(3):1075-117. PubMed ID: 23733636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose tolerability, pharmacokinetics, and pharmacodynamics of etamicastat (BIA 5-453), a new dopamine β-hydroxylase inhibitor, in healthy subjects.
    Rocha JF; Vaz-Da-Silva M; Nunes T; Igreja B; Loureiro AI; Bonifácio MJ; Wright LC; Falcão A; Almeida L; Soares-Da-Silva P
    J Clin Pharmacol; 2012 Feb; 52(2):156-70. PubMed ID: 21343348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of dopamine D1/D2 receptor complex is involved in the function of haloperidol in cardiac H9c2 cells.
    Lencesova L; Szadvari I; Babula P; Kubickova J; Chovancova B; Lopusna K; Rezuchova I; Novakova Z; Krizanova O; Novakova M
    Life Sci; 2017 Dec; 191():186-194. PubMed ID: 29054453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance.
    García-Tornadú I; Ornstein AM; Chamson-Reig A; Wheeler MB; Hill DJ; Arany E; Rubinstein M; Becu-Villalobos D
    Endocrinology; 2010 Apr; 151(4):1441-50. PubMed ID: 20147524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disruption of the D(2) dopamine receptor produces adrenergic and endothelin B receptor-dependent hypertension].
    Li X; Bek M; Asico LD; Yang Z; Rubinstein M; Grandy DK; Goldstein DS; Eisner GM; Jose PA
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):703-7. PubMed ID: 12133472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
    Nunes T; Rocha JF; Vaz-da-Silva M; Falcão A; Almeida L; Soares-da-Silva P
    Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive activity of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline (MJ 10459-2) and catecholamine reduction.
    Perhach JL; Gomoll AW
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):155-62. PubMed ID: 1188182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats.
    Banday AA; Lau YS; Lokhandwala MF
    Hypertension; 2008 Feb; 51(2):367-75. PubMed ID: 18158345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.